The role of Intravenous Levetiracetam in Treatment of Seizures in Brain Tumor Patients
Levetiracetam, tradename Keppra, is a new second generation antiepileptic drug that is being used increasingly in brain tumor patients. In patients suffering with brain tumors, seizures are one of the leading neurologic complications seen in more than 30% of patients. Levetiracetam is a pyrollidin...
Main Authors: | Ekokobe eFonkem, Paul eBricker, Diana eMungall, Jose eAceves, Eromata eEbwe, Wei eTang, BATOOL F. KIRMANI |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2013-10-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fneur.2013.00153/full |
Similar Items
-
Efficacy and Tolerability of Intravenous Levetiracetam in Children
by: Jose eAceves, et al.
Published: (2013-08-01) -
Neurobehavioral Effects of Levetiracetam in Brain Tumor Related Epilepsy
by: Abigail eBernett, et al.
Published: (2013-07-01) -
Clinical Pharmacology and Pharmacokinetics of Levetiracetam
by: Chanin Clark Wright, et al.
Published: (2013-12-01) -
Role of Intravenous Levetiracetam in Seizure Prophylaxis of Severe Traumatic Brain Injury Patients
by: BATOOL F. KIRMANI, et al.
Published: (2013-11-01) -
Role of Intravenous Levetiracetam in Acute Seizure Management
by: BATOOL F. KIRMANI
Published: (2014-06-01)